Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

BetterLife reports first behavioral animal pharmacology data on TD-0148A

Nov. 17, 2021

BioArctic developing antibody treatments targeting TDP-43 for ALS

Nov. 16, 2021

Roche discloses GABA-A receptor PAMs

Nov. 16, 2021

Sumitomo Dainippon Pharma patents new compounds for epilepsy

Nov. 16, 2021

Cold exposure ameliorates active experimental autoimmune encephalomyelitis

Nov. 16, 2021

Juva adds second novel noncannabinoid compound to pipeline

Nov. 15, 2021

Targeting pathogenic activation of autophagy in a new LGMDD2 fly model rescues muscle phenotypes

Nov. 15, 2021

ADAR1 Z alpha-domain-mutated mice display Aicardi-Goutieres syndrome defects

Nov. 15, 2021

Jmackem divulges new TRPV1 antagonists

Nov. 15, 2021

LPAR1 antagonist PIPE-791 promotes remyelination in multiple sclerosis

Nov. 15, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 19, 2026.
ASGCT 2026: Directed evolution in gene therapy
BioWorld
Directed evolution has become a central pillar in gene therapy. This engineering strategy enables the generation of more efficient variants of genetic editors and...
News in brief
BioWorld Asia
BioWorld Asia briefs for May 19, 2026
Authorities work to quickly sequence Ebola species in latest outbreak
BioWorld
If the recent hantavirus outbreak wasn’t enough to keep public health officials busy, a new Ebola virus disease outbreak has been confirmed by authorities in the...
Camp4 studies CMP-002 in SYNGAP1 haploinsufficient mouse model
BioWorld Science
Camp4 Therapeutics Corp. has highlighted new preclinical data for CMP-002, the company’s lead investigational antisense oligonucleotide (ASO) therapeutic...